US Patent Number

6610271

Publication Date

8-26-2003

Abstract

A therapeutic composition of lorazepam and its pharmaceutically acceptable derivatives are provided for intranasal administration of at least one predetermined volumetric unit dose in the form of a spray by means that delivers one or more therapeutically prescribed unit doses that are highly accurate as to the volume discharged and which leave no significant quantity of the composition in the delivery means.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

09/790,199

Filing Date

02/20/2001

Share

COinS